Teratology Society Training Program Resources

The Teratology Society collects information about training programs pertaining to teratology, developmental toxicology, or reproductive toxicology.

If you would like for your program to be listed as a resource, or if you would like to recommend a training program for this listing, please contact tshq@teratology.org.


Training Program Resources


US Environmental Protection Agency

Thomas B. Knudsen, PhD

Dr. Knudsen’s research focuses on predictive models of developmental toxicity, building and testing sophisticated computer models such as the Virtual Embryo Project. This effort explores the potential for chemicals to disrupt prenatal development—one of the most important lifestages.

Creighton University School of Medicine

Janee Gelineau-van Waes, DVM, PhD

The primary focus of the research in Dr. Gelineau-van Waes'  laboratory is the study of birth defects.  Molecular biology, proteomics, and metabolomics approaches are used to identify the underlying mechanisms that lead to placental abnormalities and embryonic/fetal malformations following gestational exposure to pharmaceuticals (anticonvulsant drugs, immunosuppressant drugs) or environmental teratogens (arsenic, mycotoxins). 

University of Texas, Austin

Richard H. Finnell, PhD

The Cell and Molecular Biology Graduate Program is an interdisciplinary program comprised of over 130 faculty from three colleges. The program typically recruits a class of 25 graduate students each year for training in seven different research tracks. Research in Dr. Finnell's laboratory focuses on the interaction between specific genes and nutritional factors as they influence normal embryonic development.

McGill University

Barbara Hales, PhD

Dr. Hales' research interests focus on mechanisms of action of drugs as teratogens. She studies developmental toxicity using a combination of in vivo, in vitro, and molecular approaches with the goal of elucidating how the embryo responds to insult after direct or maternal exposure and the consequences to progeny of paternal drug exposure.


University of Georgia

Mary Alice Smith, PhD

Dr. Smith’s laboratory develops in vitro and in vivo model systems to identify microbial and chemical agents that affect pregnancy and development and uses those models to investigate mechanisms of toxicity and develop therapies for treating adverse effects. Dr. Smith is the graduate coordinator for the Interdisciplinary Toxicology Program where students are trained broadly in toxicology and can focus their specialization in developmental toxicology.


University of Rochester Medical Center

Chris J. Stodgell, PhD

The goal of Dr. Stodgell’s research is to understand the environmental and genetic etiologies of developmental disorders, such as autism spectrum disorders. Through collaborations with other programs interested in the genetics of autism, they have studied how specific candidate genes are related to autism spectrum disorders.


Recent Stories
Structural Birth Defects Trainee Symposium to be hosted by the Society for Developmental Biology

Register Today for the Virtual Human Teratogens Course, November 2-4, 2021

Press Release: FASEB Launches Data-sharing and Reuse Initiative